Carborundum Universal Board Meets to Approve Q2 FY27 Results

Carborundum Universal Limited's board is scheduled to approve unaudited Q2 FY27 results on 2 November 2026, following 17.0% year-on-year consolidated revenue growth to ₹1,426.63 crore in Q1 FY27. The meeting matters because it will formally disclose performance for the quarter ended 30 September 2026 and provide the next reported comparison for shareholders.

When will Carborundum Universal announce Q2 FY27 results?

Carborundum Universal Limited, or CUMI, has scheduled a board meeting for 2 November 2026 to consider and approve its unaudited financial results for Q2 FY27. The results cover the period from 1 July 2026 to 30 September 2026.

The company disclosed the meeting through a routine intimation under Regulation 29 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements rules. The notice sets out the agenda of considering and approving the quarterly financial results. It does not include revenue, profit, dividend, capital expenditure, or operational information for the September quarter.

The board approval is the formal step before CUMI files the quarterly numbers with the stock exchanges. Investors will therefore have to wait for the result announcement and supporting disclosures to assess sales, margins, profitability, segment performance, and any management commentary for Q2 FY27.

The meeting was scheduled after an earlier preview noted that the statutory outer deadline for September-quarter results was 14 November 2026. The 2 November meeting brings the formal approval date ahead of that deadline.

What did CUMI report in the previous quarter?

CUMI reported consolidated revenue of ₹1,426.63 crore in Q1 FY27, up 17.0% year-on-year and 2.0% sequentially from ₹1,398.35 crore in Q4 FY26. The Q1 results were announced on 7 August 2026.

Profit attributable to owners stood at ₹76.40 crore in Q1 FY27, increasing 23.4% from ₹61.89 crore in Q1 FY26. The net profit margin improved to 5.4% from 4.9% a year earlier. Another reported presentation placed Q1 FY27 net profit at ₹80.34 crore, while the company result summary separately identifies ₹76.40 crore as profit attributable to owners.

Standalone sales were ₹846 crore in Q1 FY27, a 21.2% increase from ₹698 crore in Q1 FY26. Growth was reported across all three standalone businesses: Electrominerals sales rose 33.0%, Ceramics sales increased 15.2%, and Abrasives sales grew 14.7%.

Electrominerals also recorded an improvement in standalone segment PBIT, which rose to ₹39 crore from ₹7 crore a year earlier. The disclosed drivers were volume growth and a favourable product mix. Standalone segment PBIT overall was ₹132 crore, compared with ₹106 crore in Q1 FY26.

What is the comparison base for CUMI's September quarter?

CUMI's Q2 FY27 performance will be compared with Q2 FY26, when it reported consolidated sales of ₹1,287 crore, up 6.4% year-on-year. A separate reported base for the September 2025 quarter puts revenue at ₹1,298 crore and profit at ₹74 crore.

These reported figures provide the available year-on-year reference points for the upcoming release, but CUMI has not disclosed any Q2 FY27 estimate in its board-meeting notice. The filing also does not offer guidance on expected revenue, earnings, margins, or segment performance for the quarter.

The Q1 FY27 print provides the most recent reported operating context. Consolidated revenue growth was supported by higher standalone sales, with all three key standalone segments recording year-on-year expansion. Whether that momentum continued in the September quarter will be known only when the approved results are filed.

What guidance and operational actions has CUMI disclosed?

CUMI has previously indicated consolidated sales growth guidance of 4% to 4.5% for FY27. Excluding loss-making subsidiaries, the company indicated a sales-growth range of 11% to 12%.

The company also planned to increase capital expenditure to ₹400 crore for FY27. In addition, management has stated that it is addressing underperforming assets, including closure or divestment plans related to Auko and Foskor Zirconia. The provided information does not state whether any such actions were completed during Q2 FY27.

For the Ceramics business, management upgraded FY27 growth guidance to 23% to 25%, citing traction in engineered ceramics, metallised cylinders, and solid oxide fuel cells. This guidance was disclosed alongside the Q1 FY27 discussion and is separate from the 2 November board-meeting notice.

CUMI had also announced a $3 million, approximately ₹28.78 crore, capital infusion into wholly owned subsidiary CUMI International Limited, Cyprus, to fund the closure of its German abrasives unit. That action reflects the company's stated effort to deal with underperforming operations, but the board notice does not provide an update on the infusion or closure process.

How does the board meeting affect CUMI investors?

The board-meeting intimation itself does not change CUMI's financial position, capital structure, or operations. It is a procedural disclosure that tells investors when the board will review the September-quarter financial statements.

The Q2 FY27 result filing may influence investor assessment once actual figures are available. The main reported reference points are Q1 FY27 consolidated revenue of ₹1,426.63 crore, 17.0% year-on-year growth, and profit attributable to owners of ₹76.40 crore, up 23.4% year-on-year. Investors may also compare the September-quarter outcome with the Q2 FY26 revenue and profit base.

No dividend proposal was disclosed in the current notice. CUMI's FY26 audited results had included a recommended final dividend of ₹2.50 per share, but the Q2 FY27 board-meeting filing does not mention a dividend agenda. The available disclosure also contains no fresh forward guidance or operational update.

Conclusion

CUMI's 2 November board meeting is the scheduled approval event for unaudited Q2 FY27 results, not a disclosure of the quarter's performance. The company's latest reported quarter showed 17.0% consolidated revenue growth and a 23.4% increase in profit attributable to owners, while all three key standalone segments recorded sales growth.

The next item to watch is CUMI's exchange filing after the board meeting. Investors will look for the Q2 FY27 revenue, profit, margins, segment details, progress on loss-making subsidiaries, capital expenditure updates, and any change to the company's stated FY27 sales-growth guidance.